Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local vancomycin irrigation to reduce ventriculoperitoneal shunt infection in children with hydrocephalus
IRCT20240814062757N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2024
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of vancomycin in hydrocephalus (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Rate of shunt infection. Started Dec 2024; status: completed.
02
Drugs
vancomycin
03
Conditions
hydrocephalus
Beyond the preview
Go deeper on IRCT20240814062757N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240814062757N1.